Peanut Allergy – No Longer a Life Sentence

Authors

  • Kok Wee Chong Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK; Allergy Service, Department of Paediatric Medicine, KK Women’s and Children’s Hospital
  • Paul J. Turner Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK; Discipline of Paediatrics and Child Health, School of Medicine, University of Sydney, Sydney, New South Wales

DOI:

https://doi.org/10.5644/ama2006-124.298

Keywords:

Immunotherapy, Peanut Allergy, Prevention

Abstract

In this review we provide an overview on the latest knowledge in the prevention and active management of peanut allergy. The rise in incidence of food allergy has generated new challenges in the management of affected individuals. Strategies to counter- act the increase in prevalence of peanut allergy can be considered as a pyramid, beginning with primary prevention of those at risk through earlier introduction of peanut into the infant diet, to secondary prevention of peanut-sensitised children through improvements in the correct diagnosis of peanut allergy and finally to the treatment of children with proven peanut allergy.

Conclusion. With the paradigm shift towards an active management, peanut allergy should no longer be seen as a life sentence.

Downloads

Download data is not yet available.

Downloads

Published

2020-11-11

How to Cite

Chong, K. W., & Turner, P. J. (2020). Peanut Allergy – No Longer a Life Sentence. Acta Medica Academica, 49(2), 198–206. https://doi.org/10.5644/ama2006-124.298

Issue

Vol. 49 No. 2 (2020): Special Issue: Asthma and Allergies: From Diagnosis-Based Approach towards Personalised Treatments

Section

Clinical Science

Similar Articles

<< < 1 2 3 4 

You may also start an advanced similarity search for this article.